Provided by Tiger Fintech (Singapore) Pte. Ltd.

Mesoblast

13.55
+0.27002.03%
Post-market: 13.550.00000.00%19:05 EDT
Volume:329.44K
Turnover:4.41M
Market Cap:1.72B
PE:-15.20
High:13.58
Open:13.26
Low:13.14
Close:13.28
Loading ...
Apr 11, 2019

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Mar 28, 2019

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Mar 26, 2019

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Mar 14, 2019

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Feb 22, 2019

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Feb 22, 2019

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Feb 22, 2019

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Feb 14, 2019

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 14, 2019

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 05, 2019

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Feb 05, 2019

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Dec 23, 2016

Report of foreign issuer

中胚层和Mallinckrodt进入股权购买协议,独家谈判中胚层的细胞疗法产品的开发和商业化慢性下腰痛和急性移植物抗宿主病
Dec 13, 2016

Report of foreign issuer

美国国会立法新加速审批途径再生先进疗法
Dec 08, 2016

Report of foreign issuer

MD安德森癌症中心和美国国立卫生研究院资助的临床试验结合两项专利中胚层技术快速移植的干细胞移植在癌症患者
Nov 15, 2016

Report of foreign issuer

宣布成功临时徒劳的3期临床试验分析急性移植物抗宿主病
Nov 14, 2016

Report of foreign issuer

提供企业更新和截至9月30日的第一季度财务业绩2016